Investigational Drug Details
| Drug ID: | D466 |
| Drug Name: | ASC41 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | THR-beta agonist |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 on-going (NCT05118360) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0145 | NCT04845646 | Phase 1 | Completed | No Results Available | March 16, 2021 | July 19, 2021 | Details |
| L0273 | NCT05118360 | Phase 2 | Not yet recruiting | No Results Available | March 30, 2022 | December 28, 2021 | Details |
| L0399 | NCT04692025 | Phase 1 | Not recruiting | No Results Available | 29/12/2020 | 19 April 2021 | Details |
| L0402 | NCT04686994 | Phase 1 | Not recruiting | No Results Available | 23/12/2020 | 19 April 2021 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|